Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions (Q24198236)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457841&resulttype=core&format=json

13 May 2020

0 references

1 reference

human papilloma virus

1 reference

human papillomavirus

29 September 2024

4

Frank Buntinx

Frank

Buntinx

1 reference

19 October 2023

Evangelos Paraskevaidis

series ordinal

5

object named as

Evangelos Paraskevaidis

author given names

Evangelos

author last names

Paraskevaidis

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457841&resulttype=core&format=json

13 May 2020

19 October 2023

Pierre P L Martin-Hirsch

series ordinal

6

object named as

Pierre P L Martin-Hirsch

author given names

Pierre P L

author last names

Martin-Hirsch

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457841&resulttype=core&format=json

13 May 2020

19 October 2023

1

Marc Arbyn

Marc

Arbyn

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457841&resulttype=core&format=json

13 May 2020

19 October 2023

7

Walter J Prendiville

Walter J

Prendiville

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457841&resulttype=core&format=json

13 May 2020

19 October 2023

3

Cindy Simoens

Cindy

Simoens

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457841&resulttype=core&format=json

13 May 2020

19 October 2023

Jolien Roelens

2

Jolien

Roelens

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457841&resulttype=core&format=json

13 May 2020

Cochrane Database of Systematic Reviews

19 October 2023

language of work or name

1 reference

28 March 2013

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457841&resulttype=core&format=json

13 May 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457841&resulttype=core&format=json

13 May 2020

page(s)

CD008054

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457841&resulttype=core&format=json

The age-specific relationships of abnormal cytology and human papillomavirus DNA results to the risk of cervical precancer and cancer.

13 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Clinical performance of human papillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Human Papillomavirus testing for the management of low-grade cervical abnormalities in the UK--Influence of age and testing strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Management of women who test positive for high-risk types of human papillomavirus: the HART study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Triage of women with atypical squamous cells of undetermined significance (ASC-US): results of an Italian multicentric study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

The sensitivity and specificity of p16(INK4a) cytology vs HPV testing for detecting high-grade cervical disease in the triage of ASC-US and LSIL pap cytology results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Atypical squamous cells of undetermined significance-favour reactive compared to atypical squamous cells of undetermined significance-favour dysplasia: association with cervical intraepithelial lesions and human papillomavirus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Detection of cervical high-grade squamous intraepithelial lesions from cytologic samples using a novel immunocytochemical assay (ProEx C).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Comparison of human papillomavirus detection and typing by hybrid capture 2, linear array, DNA chip, and cycle sequencing in cervical swab samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Human papillomavirus testing improves the accuracy of colposcopy in detection of cervical intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

HPV triage for low grade (L-SIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid based cytology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Effects of age and human papilloma viral load on colposcopy triage: data from the randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

High-risk HPV testing in women with borderline and mild dyskaryosis: long-term follow-up data and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Prediction of recurrent disease by cytology and HPV testing after treatment of cervical intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Prevalence of high-risk human papillomavirus in an inner-city population with atypical squamous cells of undetermined significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Description of patients with squamous cell carcinoma in the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion triage study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Use of semi-quantitative PCR for human papillomavirus DNA type 16 to identify women with high grade cervical disease in a population presenting with a mildly dyskaryotic smear report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Quantitative detection of molecular markers ProEx C (minichromosome maintenance protein 2 and topoisomerase IIa) and MIB-1 in liquid-based cervical squamous cell cytology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

The Mexican Cervical Cancer Screening Trial: self-sampling for human papillomavirus with unaided visual inspection as a secondary screen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Refining the management of low-grade cervical abnormalities in the UK National Health Service and defining the potential for human papillomavirus testing: a commentary on emerging evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Evaluation of cervical screening strategies with adjunct high-risk human papillomavirus testing for women with borderline or mild dyskaryosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

A randomized trial of basing treatment on human papillomavirus and/or cytology results in low-grade cervical lesion triage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Atypical squamous cells of undetermined significance: human papillomavirus testing in adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Atypical squamous cells of undetermined significance, human papillomavirus, and cervical intraepithelial neoplasia 2 or 3 in adolescents: ASC-US, age, and high-grade cervical neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Age-specific prevalence of HPV genotypes in cervical cytology samples with equivocal or low-grade lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Human papillomavirus infection and its association with cervical dysplasia in Ecuadorian women attending a private cancer screening clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Role of P16(INK4a) expression in identifying CIN2 or more severe lesions among HPV-positive patients referred for colposcopy after abnormal cytology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Comparison of HPV genotyping by type-specific PCR and sequencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Neither one-time negative screening tests nor negative colposcopy provides absolute reassurance against cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Five-year experience of human papillomavirus DNA and Papanicolaou test cotesting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Impact of improved classification on the association of human papillomavirus with cervical precancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Association of polymorphism in FcGR3A gene and progression of low-grade precursor lesions of cervical carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Is human papillomavirus viral load a clinically useful predictive marker? A longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Cross sectional study of conventional cervical smear, monolayer cytology, and human papillomavirus DNA testing for cervical cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Molecular analysis of HPV 16 E6I/E6II spliced mRNAs and correlation with the viral physical state and the grade of the cervical lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Clinical performance of the APTIMA HPV Assay for the detection of high-risk HPV and high-grade cervical lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Clinical validation of the Cervista HPV HR and 16/18 genotyping tests for use in women with ASC-US cytology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Reflex human papilloma virus infection testing detects the same proportion of cervical intraepithelial neoplasia grade 2-3 in young versus elderly women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

The significance of marked nuclear atypia in grade 1 cervical intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Does typing of human papillomavirus assist in the triage of women with repeated low-grade, cervical cytologic abnormalities?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Contribution of human papillomavirus testing by hybrid capture in the triage of women with repeated abnormal pap smears before colposcopy referral

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Value of combining HPV-DNA testing with follow-up Papanicolaou smear in patients with prior atypical squamous cells of undetermined significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Reflex high-risk human papillomavirus DNA testing (Hybrid Capture 2) of bloody ThinPrep specimens with atypical squamous cells of undetermined significance interpretation: does pretreatment with acetic acid affect test performance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Human papillomavirus 'reflex' testing as a screening method in cases of minor cytological abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Human papillomavirus typing in patients with Papanicolaou smears showing squamous atypia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Immunohistochemical expression of p16INK4a and bcl-2 according to HPV type and to the progression of cervical squamous intraepithelial lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Human papillomavirus genotyping for the eight oncogenic types can improve specificity of HPV testing in women with mildly abnormal Pap results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Outcome of "Atypical squamous cells" in a cervical cytology screening program: implications for follow up in resource limited settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Comparison between the Hybrid Capture 2 and the hpVIR real-time PCR for detection of human papillomavirus in women with ASCUS or low grade dysplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Prospective evaluation of the Hybrid Capture 2 and AMPLICOR human papillomavirus (HPV) tests for detection of 13 high-risk HPV genotypes in atypical squamous cells of uncertain significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

The clinical performance of Invader technology and SurePath when detecting the presence of high-risk HPV cervical infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

An evaluation of human papillomavirus testing for intermediate- and high-risk types as triage before colposcopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Human papillomavirus status in the prediction of high-grade cervical intraepithelial neoplasia in patients with persistent low-grade cervical cytological abnormalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

HPV triage testing or repeat Pap smear for the management of atypical squamous cells (ASCUS) on Pap smear: is there evidence of process utility?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Managing atypical squamous cells of undetermined significance (ASCUS): human papillomavirus testing, ASCUS subtyping,or follow-up cytology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

The utility of HPV DNA triage in the management of cytological AGC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

A weakly positive human papillomavirus Hybrid Capture II result correlates with a significantly lower risk of cervical intraepithelial neoplasia 2,3 after atypical squamous cells of undetermined significance cytology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

NucliSENS EasyQ HPV v1 test - Testing for oncogenic activity of human papillomaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Visual appearance of the uterine cervix: correlation with human papillomavirus detection and type

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Is smoking an independent risk factor for invasive cervical cancer? A nested case-control study within Nordic biobanks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Human papillomavirus testing as triage for atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions: Sensitivity, specificity, and cost-effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Cervical cancer screening with liquid cytology in women with developmental disabilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Comparison of HPV detection technologies: Hybrid capture 2, PreTect HPV-Proofer and analysis of HPV DNA viral load in HPV16, HPV18 and HPV33 E6/E7 mRNA positive specimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Resolution of equivocal results with the Hybrid Capture II high-risk HPV DNA test: a cytologic/histologic review of 191 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Correlation between hybrid capture II high-risk human papillomavirus DNA test chemiluminescence intensity from cervical samples with follow-up histologic results: a cytologic/histologic review of 367 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

p16INK4A immunohistochemistry is superior to HPV in situ hybridization for the detection of high-risk HPV in atypical squamous metaplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Analyses of atypical squamous cells refined by the 2001 Bethesda System: the distribution and clinical significance of follow-up management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Lifetime effects, costs, and cost effectiveness of testing for human papillomavirus to manage low grade cytological abnormalities: results of the NHS pilot studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Papillary squamous intraepithelial lesions of the uterine cervix: human papillomavirus-dependent changes in cell cycle expression and cytologic features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Cervical dysplasia: assessing methylation status (Methylight) of CCNA1, DAPK1, HS3ST2, PAX1 and TFPI2 to improve diagnostic accuracy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Testing for methylated PCDH10 or WT1 is superior to the HPV test in detecting severe neoplasms (CIN3 or greater) in the triage of ASC-US smear results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Gene expression profiling in cervical cancer: identification of novel markers for disease diagnosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

HPV testing for triage of HIV-infected women with papanicolaou smears read as atypical squamous cells of uncertain significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

The accuracy of colposcopic grading for detection of high-grade cervical intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Human papillomavirus triage of atypical squamous cells of undetermined significance: cost-effective, but at what cost?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Long-term follow-up of cervical disease in women screened by cytology and HPV testing: results from the HART study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Multiplex chemiluminescence microscope imaging of P16(INK4A) and HPV DNA as biomarker of cervical neoplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Comparison of AMPLICOR and Hybrid Capture II assays for high risk HPV detection in normal and abnormal liquid-based cytology: use of INNO-LiPA Genotyping assay to screen the discordant results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion: cytohistologic correlation study with diagnostic pitfalls

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Lessons from practice: risk of CIN 3 or cancer associated with an LSIL or HPV-positive ASC-US screening result in women aged 21 to 24.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Conservative management of adolescents with abnormal cytology and histology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Utilization of human papillomavirus testing for cervical cancer prevention in a university hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Correlation of Pap smear, cervical biopsy, and clinical follow-up with an HPV typing microarray system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Human papillomavirus genotypes in asymptomatic young women from public schools in Rio de Janeiro, Brazil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Human papilloma virus infection and cervical intraepithelial neoplasia in transplanted patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Atypical squamous cells, cannot exclude a high-grade intraepithelial lesion and its clinical significance in postmenopausal, pregnant, postpartum, and contraceptive-use patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Impact of reflex HPV testing on interpretation and management of ThinPrep Pap tests.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Does the ThinPrep Imaging System increase the detection of high-risk HPV-positive ASC-US and AGUS? The Women and Infants Hospital experience with over 200,000 cervical cytology cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Role of HPV DNA testing in predicting cervical intraepithelial lesions: comparison of HC HPV and ISH HPV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Human papillomavirus-specific genotypes in cervical lesions of women referred for smears with atypical glandular cells or adenocarcinoma in situ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Prognostic significance of the detection of human papilloma virus L1 protein in smears of mild to moderate cervical intraepithelial lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Detection of telomerase, its components, and human papillomavirus in cervical scrapings as a tool for triage in women with cervical dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Atypical glandular cells of undetermined significance (AGUS): cytopathologic features, histopathologic results, and human papillomavirus DNA detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Management and triage of women with human papillomavirus infection in follow-up for low-grade cervical disease: association of HPV-DNA and RNA-based methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

p16(INK4a) is superior to high-risk human papillomavirus testing in cervical cytology for the prediction of underlying high-grade dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Performance of Pap smear and human papilloma virus testing in the follow-up of women with cervical intraepithelial neoplasia grade 1 managed conservatively.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Optimal threshold for a positive hybrid capture 2 test for detection of human papillomavirus: data from the ARTISTIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Increased risk of oncogenic human papillomavirus infections and incident high-grade cervical intraepithelial neoplasia among smokers: experience from the Latin American screening study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Reflex human papillomavirus DNA testing on residual liquid-based (TPPT) cervical samples: focus on age-stratified clinical performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

When to test women for human papillomavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Quantitative multiplex PCR assay for the detection of the seven clinically most relevant high-risk HPV types

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Clinical significance of atypical glandular cells on cervical cytology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Resolving repeatedly borderline results of Hybrid Capture 2 HPV DNA Test using polymerase chain reaction and genotyping

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

The utility of human papillomavirus testing in the management of atypical glandular cells on cytology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Human papillomavirus testing for cervical cancer screening: results from a 6-year prospective study in rural China

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Hybrid capture 2 human papillomavirus DNA testing for women with atypical squamous cells of undetermined significance Papanicolaou results in SurePath and ThinPrep specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Detecting high-grade cervical disease on ASC-H cytology: role of BD ProEx C and Digene Hybrid Capture II HPV DNA testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Co-expression of p53 and Bcl-2 proteins in human papillomavirus-induced premalignant lesions of the uterine cervix: correlation with progression to malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Prevalence of human papillomavirus types 6, 11, 16 and 18 in young Austrian women - baseline data of a phase III vaccine trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Triage of women with minor cervical lesions: data suggesting a "test and treat" approach for HPV E6/E7 mRNA testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Comparison of the Digene Hybrid Capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal Pap smear results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Use of the ThinPrep Imaging System does not alter the frequency of interpreting Papanicolaou tests as atypical squamous cells of undetermined significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Women >or=30 years of age with low grade squamous intraepithelial lesion (LSIL) have low positivity rates when cotested for high-risk human papillomavirus: should we reconsider HPV triage for LSIL in older women?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Genomic amplification of the human telomerase RNA gene for differential diagnosis of cervical disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Cost-effectiveness of using human papillomavirus 16/18 genotype triage in cervical cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Combining HPV and MIB-1 tests reduces the number of colposcopies in women with equivocal cytology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Human papillomavirus (HPV) in atypical squamous cervical cytology: the Invader HPV test as a new screening assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Comparison of management algorithms for the evaluation of women with low-grade cytologic abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Human papillomavirus triage for young women with atypical squamous cells of undetermined significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Reflex high-risk human papilloma virus DNA test is useful in the triage of women with atypical squamous cells cannot exclude high-grade squamous intraepithelial lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Human papillomavirus type 18 DNA load and 2-year cumulative diagnoses of cervical intraepithelial neoplasia grades 2-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Comparison of three management strategies for patients with atypical squamous cells of undetermined significance, after six months delay: a three-year experience in an Iranian university hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Diagnostic value of p16INK4A, Ki-67, and human papillomavirus L1 capsid protein immunochemical staining on cell blocks from residual liquid-based gynecologic cytology specimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Histologic follow-up results in 662 patients with Pap test findings of atypical glandular cells: results from a large academic womens hospital laboratory employing sensitive screening methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Atypical squamous cells of undetermined significance: Bethesda classification and association with Human Papillomavirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Triage of cervical cytological diagnoses of atypical squamous cells by DNA methylation of paired boxed gene 1 (PAX1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Performance of the Aptima High-Risk Human Papillomavirus mRNA Assay in a Referral Population in Comparison with Hybrid Capture 2 and Cytology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Human papillomavirus (HPV) DNA triage of women with atypical squamous cells of undetermined significance with Amplicor HPV and Hybrid Capture 2 assays for detection of high-grade lesions of the uterine cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Evaluation of CINtec PLUS® testing as an adjunctive test in ASC-US diagnosed SurePath® preparations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

HPV Test Results Stratify Risk for Histopathologic Follow-Up Findings of High-Grade Cervical Intra-Epithelial Neoplasia in Women with Low-Grade Squamous Intra-Epithelial Lesion Pap Results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

The diagnostic accuracy of two methods for E6&7 mRNA detection in women with minor cytological abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Human papillomavirus (HPV) DNA triage of women with atypical squamous cells of undetermined significance with cobas 4800 HPV and Hybrid Capture 2 tests for detection of high-grade lesions of the uterine cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

CINtec® PLUS dual immunostain: a triage tool for cervical pap smears with atypical squamous cells of undetermined significance and low grade squamous intraepithelial lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: the FASE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

The Evaluation of p16ink4a Immunoexpression/Immunostaining and Human Papillomavirus DNA Test in Cervical Liquid-Based Cytological Samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Human papillomavirus viral load expressed as relative light units (RLU) correlates with the presence and grade of preneoplastic lesions of the uterine cervix in atypical squamous cells of undetermined significance (ASCUS) cytology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Clinical performance of the CLART human papillomavirus 2 assay compared with the hybrid capture 2 test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Aptima HPV E6/E7 mRNA test is as sensitive as Hybrid Capture 2 Assay but more specific at detecting cervical precancer and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

p16/ki-67 dual-stain cytology in the triage of ASCUS and LSIL papanicolaou cytology: results from the European equivocal or mildly abnormal Papanicolaou cytology study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

APTIMA HPV assay performance in women with atypical squamous cells of undetermined significance cytology results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Comparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: the Predictors 2 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

High-risk human papillomavirus DNA test and p16INK4a in the triage of LSIL: A prospective diagnostic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Clinical performance of a human papillomavirus messenger RNA test (Aptima HPV Assay) on residual material from archived 3-year-old PreservCyt samples with low-grade squamous intraepithelial lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Efficacy of Abbott RealTime High Risk HPV test in evaluation of atypical squamous cells of undetermined significance from an Asian screening population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Comparison of the GenoFlow human papillomavirus (HPV) test and the Linear Array assay for HPV screening in an Asian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Re: Have We Resolved How To Triage Equivocal Cervical Cytology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Liquid compared with conventional cervical cytology: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Trends of cervical cancer mortality in the member states of the European Union

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

How to evaluate emerging technologies in cervical cancer screening?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

The APTIMA HPV assay versus the hybrid capture 2 test in triage of women with ASC‐US or LSIL cervical cytology: A meta‐analysis of the diagnostic accuracy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

The causal relation between human papillomavirus and cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Management of women with cervical cytology interpreted as ASC-US or as ASC-H.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

A report on the current status of European research on the use of human papillomavirus testing for primary cervical cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Terminology in gynaecological cytopathology: report of the Working Party of the British Society for Clinical Cytology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Viral testing for genital human papillomavirus infections: recent progress and clinical potentials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Management of women with mild and moderate cervical dyskaryosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

European guidelines for quality assurance in cervical cancer screening: recommendations for cervical cytology terminology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Observer variation in histopathological diagnosis and grading of cervical intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

European guidelines for clinical management of abnormal cervical cytology, part 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

The Bethesda System for reporting cervical/vaginal cytologic diagnoses: report of the 1991 Bethesda workshop. The Bethesda System Editorial Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Regression of low-grade squamous intra-epithelial lesions in young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Effect of testing for human papillomavirus as a triage during screening for cervical cancer: observational before and after study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

The impact of loop diathermy on management of early invasive cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Dysplasia and the natural history of cervical cancer: Early results of the Toronto cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Observer variation in gynaecological cytopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worse

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

An evaluation of bivariate random-effects meta-analysis for the joint synthesis of two correlated outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Risk of cervical cancer associated with mild dyskaryosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Observer variability in histopathological reporting of cervical biopsy specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

p16INK4a immunocytochemistry versus human papillomavirus testing for triage of women with minor cytologic abnormalities: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

A 21-year-old woman with atypical squamous cells of undetermined significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

The 2001 Bethesda System: terminology for reporting results of cervical cytology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Management of women with mild dyskaryosis. Immediate referral to colposcopy is safer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Grading the severity of cervical neoplasia based on combined histopathology, cytopathology, and HPV genotype distribution among 1,700 women referred to colposcopy in Oklahoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Anxiety caused by abnormal result of cervical smear test: a controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

2001 Consensus Guidelines for the management of women with cervical cytological abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Cervical cancer as a priority for prevention in different world regions: an evaluation using years of life lost

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Determinants of human papillomavirus-negative, low-grade squamous intraepithelial lesions in the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesions triage study (ALTS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Effect of HIV Infection on Atypical Squamous Cells of Undetermined Significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

High-throughput two-step LNA real time PCR assay for the quantitative detection and genotyping of HPV prognostic-risk groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Detection of high-risk human papillomavirus (HPV) DNA by Hybrid Capture II in women referred due to atypical glandular cells in the primary screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

p16/Ki-67 dual staining in cervico-vaginal cytology: Correlation with histology, Human Papillomavirus detection and genotyping in women undergoing colposcopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Bivariate meta-analysis of sensitivity and specificity with sparse data: a generalized linear mixed model approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Inflation of Sensitivity of Cervical Cancer Screening Tests Secondary to Correlated Error in Colposcopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Predictors of human papillomavirus persistence among women with equivocal or mildly abnormal cytology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Smoking worsens the prognosis of mild abnormalities in cervical cytology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Immunocytochemical Expression of p16INK4A and Ki-67 in Cytologically Negative and Equivocal Pap Smears Positive for Oncogenic Human Papillomavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008054.PUB2

Natural history of dysplasia of the uterine cervix

21 January 2018

1 reference

12 December 2020

A systematic review of the role of human papillomavirus testing within a cervical screening programme

1 reference

12 December 2020

Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial

1 reference

12 December 2020

High-risk HPV DNA detection by Hybrid Capture II. An adjunctive test for mildly abnormal cytologic smears in women > or = 50 years of age

1 reference

12 December 2020

Human papillomavirus testing in women with mild cytologic atypia

1 reference

12 December 2020

Quantitative detection of oncogenic HPV DNA using hybrid capture to triage borderline and mildly dyskaryotic Papanicolaou smears

1 reference

12 December 2020

Prediction of cervical intraepithelial neoplasia grade 2-3 using risk assessment and human papillomavirus testing in women with atypia on papanicolaou smears

1 reference

12 December 2020

Comparison of human papillomavirus DNA testing and repeat Papanicolaou test in women with low-grade cervical cytologic abnormalities: a randomized trial. HPV Effectiveness in Lowgrade Paps (HELP) Study No. 1 Group

1 reference

12 December 2020

Molecular detection of human papillomavirus in women with minor-grade cervical cytology abnormalities

1 reference

12 December 2020

Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial

1 reference

12 December 2020

Human papillomavirus testing and the management of women with mildly abnormal cervical smears: an observational study

1 reference

12 December 2020

A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations

1 reference

12 December 2020

Managing atypical squamous cells of undetermined significance in Papanicolaou smears

1 reference

12 December 2020

Is the human papillomavirus test in combination with the Papanicolaou test useful for management of patients with diagnoses of atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesions?

1 reference

12 December 2020

[Detection of human papillomavirus DNA using hybrid capture does not allow sufficient triaging of recurrent atypical pap smear classified as Pap III D]

1 reference

12 December 2020

Comparison of two signal-amplification DNA tests for high-risk HPV as an aid to colposcopy.

1 reference

12 December 2020

Utility of HPV DNA detection in thin-layer, liquid-based tests with atypical squamous metaplasia

1 reference

12 December 2020

Human papillomavirus DNA detection in the management of women with twice mildly abnormal cytological smears

1 reference

12 December 2020

Role for HPV testing in ASCUS: a cytologic-histologic correlation

1 reference

12 December 2020

BSCC terminology conference, koilocytosis and mild dyskaryosis

1 reference

12 December 2020

Triage of atypical squamous cells of undetermined significance with hybrid capture II: colposcopy and histologic human papillomavirus correlation

1 reference

12 December 2020

Histopathologic extent of cervical intraepithelial neoplasia 3 lesions in the atypical squamous cells of undetermined significance low-grade squamous intraepithelial lesion triage study: implications for subject safety and lead-time bias

1 reference

12 December 2020

Triage by HPV-DNA testing: is it useful in women with persistent minor smear abnormalities?

1 reference

12 December 2020

Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia.

1 reference

12 December 2020

Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance

1 reference

12 December 2020

Detection of cervical intraepithelial neoplasia in women with atypical squamous or glandular cells of undetermined significance cytology: a prospective study

1 reference

12 December 2020

An evaluation of human papillomavirus testing as part of referral to colposcopy clinics

1 reference

12 December 2020

Evaluation of adjunctive HPV testing by Hybrid Capture II®in women with minor cytological abnormalities for the diagnosis of CIN2/3 and cost comparison with colposcopy

1 reference

12 December 2020

Contribution of high risk human papillomavirus testing to the management of premalignant and malignant lesions of the uterine cervix

1 reference

12 December 2020

The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews

1 reference

12 December 2020

The triage of squamous cell abnormalities of cervical cytology by human papilloma virus screening.

1 reference

12 December 2020

Atypical glandular cells of undetermined significance. Outcome predictions based on human papillomavirus testing

1 reference

12 December 2020

Human papillomavirus viral load in predicting high-grade CIN in women with cervical smears showing only atypical squamous cells or low-grade squamous intraepithelial lesion

1 reference

12 December 2020

Prevalence and typing of HPV DNA by hybrid capture II in women with ASCUS, ASC-H, LSIL, and AGC on ThinPrep Pap tests

1 reference

12 December 2020

Five-year follow-up of women with borderline and mildly dyskaryotic cervical smears

1 reference

12 December 2020

ASC-US and HPV testing in women aged 40 years and over

1 reference

12 December 2020

The predictive value of p16(INK4a) and hybrid capture 2 human papillomavirus testing for high-grade cervical intraepithelial neoplasia

1 reference

12 December 2020

Human papillomavirus DNA detection and histological findings in women referred for atypical glandular cells or adenocarcinoma in situ in their Pap smears

1 reference

12 December 2020

Triage with human papillomavirus testing of women with cytologic abnormalities prompting referral for colposcopy assessment

1 reference

12 December 2020

Predicting CIN2 when detecting HPV mRNA and DNA by PreTect HPV-proofer and consensus PCR: A 2-year follow-up of women with ASCUS or LSIL Pap smear

1 reference

12 December 2020

A study of the impact of adding HPV types to cervical cancer screening and triage tests

1 reference

12 December 2020

Dysplasia associated with atypical glandular cells on cervical cytology

1 reference

12 December 2020

Lack of adherence to practice guidelines for women with atypical glandular cells on cervical cytology

1 reference

12 December 2020

Reflex high-risk human papillomavirus testing for women with atypical squamous cells of undetermined significance in cytologic smears: effects since implementation in a large clinical practice

1 reference

12 December 2020

Triage using HPV-testing in persistent borderline and mildly dyskaryotic smears: proposal for new guidelines

1 reference

12 December 2020

Atypical squamous cells, cannot exclude a high-grade squamous intraepithelial lesion: the practice experience of a hospital-based reference laboratory with this new Bethesda system diagnostic category

1 reference

12 December 2020

Is p16(INK4A) expression more useful than human papillomavirus test to determine the outcome of atypical squamous cells of undetermined significance-categorized Pap smear? A comparative analysis using abnormal cervical smears with follow-up biopsies

1 reference

12 December 2020

Genital human papillomavirus testing by in situ hybridization in liquid atypical cytologic materials and follow-up biopsies

1 reference

12 December 2020

HPV triage of women with atypical squamous cells of undetermined significance: a 3-year experience in an Italian organized programme

1 reference

12 December 2020

Test performance comparison of inform HPV and hybrid capture 2 high-risk HPV DNA tests using the SurePath liquid-based Pap test as the collection method

1 reference

12 December 2020

The impact of high risk human papillomavirus testing in an inner London colposcopy clinic

1 reference

12 December 2020

HPV DNA testing in the triage of atypical squamous cells of undetermined significance (ASCUS): cost comparison of two methods

1 reference

12 December 2020

Performance of the Roche AMPLICOR human papillomavirus (HPV) test in prediction of cervical intraepithelial neoplasia (CIN) in women with abnormal PAP smear

1 reference

12 December 2020

Should women with atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion, receive reflex human papillomavirus-DNA testing?

1 reference

12 December 2020

Atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion: diagnostic performance, human papillomavirus testing, and follow-up results

1 reference

12 December 2020

Which test is a better strategy to determine the outcome of atypical glandular cell-categorized Pap smears? Immunocytochemical p16INK4A expression or human papillomavirus test--a retrospective cohort study

1 reference

12 December 2020

Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence

1 reference

12 December 2020

A comparison of the human papillomavirus test and Papanicolaou smear as a second screening method for women with minor cytological abnormalities

1 reference

12 December 2020

A comparison of a prototype PCR assay and hybrid capture 2 for detection of carcinogenic human papillomavirus DNA in women with equivocal or mildly abnormal papanicolaou smears.

1 reference

12 December 2020

Clinical question: ask the experts. A 45-year-old woman seeks treatment at your clinic with atypical squamous cells from Pap smear results

1 reference

12 December 2020

1 reference

12 December 2020

Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes

1 reference

12 December 2020

Role of human papillomavirus DNA testing in management of women with atypical squamous cells of undetermined significance

1 reference

12 December 2020

High-risk human papillomavirus DNA testing: a marker for atypical glandular cells

1 reference

12 December 2020

Usefulness of combining testing for p16 protein and human papillomavirus (HPV) in cervical carcinoma screening

1 reference

12 December 2020

[Assessment of human papillomavirus testing on liquid-based Cyto-screen system for women with atypical squamous cells of undetermined significance. Effect of age]

1 reference

12 December 2020

ASC-H in Pap test--definitive categorization of cytomorphological spectrum

1 reference

12 December 2020

Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): Trial design

1 reference

12 December 2020

Human papillomavirus type-specific 18-month risk of high-grade cervical intraepithelial neoplasia in women with a normal or borderline/mildly dyskaryotic smear

1 reference

12 December 2020

Clinical significance of cytologic diagnosis of atypical squamous cells, cannot exclude high grade, in perimenopausal and postmenopausal women

1 reference

12 December 2020

Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS)

1 reference

12 December 2020

Clinical implications of the diagnosis "atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion" in pregnant women

1 reference

12 December 2020

Introducing HPV triage into the English cervical cancer screening program: consequences for participation

1 reference

12 December 2020

Human papillomavirus genotypes and the cumulative 2-year risk of cervical precancer

1 reference

12 December 2020

Clinical utility of atypical glandular cells (AGC) classification: cytohistologic comparison and relationship to HPV results

1 reference

12 December 2020

A comparison of the clinical utility of p16(INK4a) immunolocalization with the presence of human papillomavirus by hybrid capture 2 for the detection of cervical dysplasia/neoplasia

1 reference

12 December 2020

Prognostic markers of high-grade squamous intraepithelial lesions: the role of p16INK4a and high-risk human papillomavirus

1 reference

12 December 2020

[Contribution of HPV sequences detection in cervical carcinoma screening]

1 reference

12 December 2020

The expanded use of HPV testing in gynecologic practice per ASCCP-guided management requires the use of well-validated assays

1 reference

12 December 2020

An economic analysis of human papillomavirus triage for the management of women with atypical and abnormal Pap smear results in Germany

1 reference

12 December 2020

High-risk human papillomavirus DNA testing and high-grade cervical intraepithelial lesions

1 reference

12 December 2020

HPV DNA testing as an adjunct in the management of patients with low grade cytological lesions in Finland

1 reference

12 December 2020

A follow-up study of atypical squamous cells in gynecologic cytology using conventional papanicolaou smears and liquid-based preparations: the impact of the Bethesda System 2001

1 reference

12 December 2020

Should LSIL with ASC-H (LSIL-H) in cervical smears be an independent category? A study on SurePath specimens with review of literature

1 reference

12 December 2020

Is atypical squamous cells that cannot exclude high-grade squamous intraepithelial lesion clinically significant?

1 reference

12 December 2020

[Assessment of cervical intraepithelial neoplasia (CIN) lesions by DNA image cytometry].

1 reference

12 December 2020

European guidelines for quality assurance in cervical cancer screening: recommendations for collecting samples for conventional and liquid-based cytology

1 reference

12 December 2020

Evaluation of primers and PCR performance on HPV DNA screening in normal and low grade abnormal cervical cells.

1 reference

12 December 2020

ASC-US diagnosis and triage

1 reference

12 December 2020

Comparison of the AMPLICOR human papillomavirus test and the hybrid capture 2 assay for detection of high-risk human papillomavirus in women with abnormal PAP smear

1 reference

12 December 2020

Comparative evaluation of smear cytology & hybrid capture II for the diagnosis of cervical cancer

1 reference

12 December 2020

Outcomes of women with atypical squamous cells of undetermined significance and high-risk human papillomavirus DNA

1 reference

12 December 2020

A human papillomavirus testing system in women with abnormal Pap results: a comparison study with follow-up biopsies

1 reference

12 December 2020

Outcome analysis of 4 years' follow-up of patients referred for colposcopy with one smear showing mild dyskaryosis

1 reference

12 December 2020

[The clinical significance and management of cervico-cytologically diagnosed ASCUS/LSIL]

1 reference

12 December 2020

[Application of high-risk human papillomavirus testing in women with abnormal cytology]

1 reference

12 December 2020

Longitudinal cytological follow-up of patients with a papanicolaou test interpretation of "atypical squamous cells of undetermined significance" that was followed by a negative reflex test for high-risk human papillomavirus types

1 reference

12 December 2020

[Progression and regression low grade intraepitelial squamous lesions in context of positivity of high risk human papillomavirus]

1 reference

12 December 2020

Why CIN3 and CIN2 should be distinguished on histological reports

1 reference

12 December 2020

Comparison of p16INK4A and Hybrid Capture 2 human papillomavirus testing as adjunctive tests in liquid-based gynecologic SurePath preparations

1 reference

12 December 2020

Evaluation of primary cervical cancer screening with an oncogenic human papillomavirus DNA test and cervical cytologic findings among women who attended family planning clinics in the United States

1 reference

12 December 2020

Human papillomaviruses

1 reference

12 December 2020

[Expression of epidermal growth factor receptor and the correlation with HPV16/18 infection in cervical intraepithelial neoplasia and cervical carcinoma]

1 reference

12 December 2020

Immunocytochemical staining of p16(ink4a) protein as an adjunct test in equivocal liquid-based cytology

1 reference

12 December 2020

[Importance of human papillomavirus (HPV) screening in the follow-up after CIN2-3 treatment]

1 reference

12 December 2020

Detection of human papillomavirus genotypes among high-risk women: a comparison of hybrid capture and linear array tests

1 reference

12 December 2020

HPV testing as an adjunct to cytology in the follow up of women treated for cervical intraepithelial neoplasia

1 reference

12 December 2020

Human papillomavirus genotype distribution in low-grade squamous intraepithelial lesions in France and comparison with CIN2/3 and invasive cervical cancer: the EDiTH III study

1 reference

12 December 2020

Longitudinal clinical evaluation of a novel antibody cocktail for detection of high-grade squamous intraepithelial lesions on cervical cytology specimens.

1 reference

12 December 2020

Are adjunctive markers useful in routine cervical cancer screening? Application of p16(INK4a) and HPV-PCR on ThinPrep samples with histological follow-up

1 reference

12 December 2020

Morphologic, patient and interpreter profiles of high-risk human papillomavirus-positive vs.-negative cases of atypical squamous cells of undetermined significance

1 reference

12 December 2020

Linear array genotyping and hybrid capture II assay in detecting human papillomavirus genotypes in women referred for colposcopy due to abnormal Papanicolaou smear

1 reference

12 December 2020

Significance of high-risk human papillomavirus DNA-positive atypical squamous cells of undetermined significance pap smears in perimenopausal and postmenopausal women

1 reference

12 December 2020

HPV detection and genotyping as an earlier approach in cervical cancer screening of the female genital tract.

1 reference

12 December 2020

Cytological distinction between high-risk and low-risk human papillomavirus infections in SurePath liquid-based cell preparations

1 reference

12 December 2020

ProEx C immunocytochemistry and high-risk human papillomavirus DNA testing in papanicolaou tests with atypical squamous cell (ASC-US) cytology: correlation study with histologic biopsy

1 reference

12 December 2020

Oncogenic human papillomavirus testing in an adolescent population with atypical squamous cells of undetermined significance

1 reference

12 December 2020

Cervical infections by multiple human papillomavirus (HPV) genotypes: Prevalence and impact on the risk of precancerous epithelial lesions

1 reference

12 December 2020

The evaluation of human papillomavirus genotyping in cervical liquid-based cytology specimens; using the Roche Linear Array HPV genotyping assay

1 reference

12 December 2020

Cervical cytology screening and management of abnormal cytology in adolescents

1 reference

12 December 2020

High-risk human papillomavirus DNA test results are useful for disease risk stratification in women with unsatisfactory liquid-based cytology pap test results

1 reference

12 December 2020

A 7.5-year prospective study of longer than 18 months type-specific human papillomavirus persistence in a routine cytology-based cervical screening population of about 31,000 women in West Germany

1 reference

12 December 2020

Statement on HPV DNA test utilization

1 reference

12 December 2020

[Comparison of efficacy of combined use of liquid cytology and immunohistochemical assay of p16ink4 and standard procedure and high risk evaluation by polymerase chain reaction of human papillomavirus infection in diagnosing cervical dysplasia and c

1 reference

12 December 2020

HPV screening for cervical cancer in rural India

1 reference

12 December 2020

Clinical performance of Abbott RealTime High Risk HPV test for detection of high-grade cervical intraepithelial neoplasia in women with abnormal cytology

1 reference

12 December 2020

High-risk HPV detection and concurrent HPV 16 and 18 typing with Abbott RealTime High Risk HPV test

1 reference

12 December 2020

Efficiency of the APTIMA HPV Assay for detection of HPV RNA and DNA targets

1 reference

12 December 2020

Value of p16INK4a as a marker of progression/regression in cervical intraepithelial neoplasia grade 1

1 reference

12 December 2020

Value of high-risk HPV-DNA testing in the triage of ASCUS

1 reference

12 December 2020

The challenges of organising cervical screening programmes in the 15 old member states of the European Union

1 reference

12 December 2020

Image-guided ThinPrep Papanicolaou tests and cotesting with high-risk human papillomavirus in women aged 30 years and older in a low-risk private practice population

1 reference

12 December 2020

Follow-up findings for women with human papillomavirus-positive and atypical squamous cells of undetermined significance screening test results in a large women's hospital practice

1 reference

12 December 2020

Comparison of HPV and cytology triage algorithms for women with borderline or mild dyskaryosis in population-based cervical screening (VUSA-screen study).

1 reference

12 December 2020

The use of p16(INK4A) immunocytochemistry in "Atypical squamous cells which cannot exclude HSIL" compared with "Atypical squamous cells of undetermined significance" in liquid-based cervical smears

1 reference

12 December 2020

[The role of colposcopy and typization of human papillomavirus in further diagnostic proceedings in patients with ASC-US cytological finding of the uterine cervix]

1 reference

12 December 2020

The Abbott RealTime High Risk HPV test: comparative evaluation of analytical specificity and clinical sensitivity for cervical carcinoma and CIN 3 lesions with the Hybrid Capture 2 HPV DNA test

1 reference

12 December 2020

Human papillomavirus typing and viral gene expression analysis for the triage of women with abnormal results from papanicolaou test smears to colposcopy

1 reference

12 December 2020

Comparison of the clinical significance of the Papanicolaou test interpretations LSIL cannot rule out HSIL and ASC-H.

1 reference

12 December 2020

Living with uncertainty: equivocal Pap test results and the evolution of ASC terminology

1 reference

12 December 2020

HPV vaccine protein L1 predicts disease outcome of high-risk HPV early squamous dysplastic lesions

1 reference

12 December 2020

Comparison of the clinical performance of carcinogenic HPV typing of the Linear Array and Papillocheck HPV-screening assay.

1 reference

12 December 2020

Relevance of HPV mRNA detection in a population of ASCUS plus women using the NucliSENS EasyQ HPV assay

1 reference

12 December 2020

P634A4 and TAp73 immunocytochemistry in liquid-based cervical cytology--potential biomarkers for diagnosis and progress prediction of cervical neoplasia

1 reference

12 December 2020

[The significance of HPV-DNA genotyping assays in the ASC]

1 reference

12 December 2020

ACOG Practice Bulletin no. 109: Cervical cytology screening

1 reference

12 December 2020

Detection of high risk human papillomavirus cervical infections by the hybrid capture in Asunción, Paraguay

1 reference

12 December 2020

A randomized controlled trial of Human Papillomavirus (HPV) testing for cervical cancer screening: trial design and preliminary results (HPV FOCAL Trial)

1 reference

12 December 2020

Cervical neoplasia guidelines: United States and europe compared

1 reference

12 December 2020

The relationship between HPV16 and HPV18 viral load and cervical lesions progression.

1 reference

12 December 2020

The role of human papillomavirus testing in the management of women with low-grade abnormalities: multicentre randomised controlled trial

1 reference

12 December 2020

Human papillomavirus-based triage of women showing a cervical cytology result of borderline or mild dyskaryosis

1 reference

12 December 2020

Assessment of HPV DNA test value in management women with cytological findings of ASC-US, CIN1 and CIN2

1 reference

12 December 2020

Human papillomavirus genotypes in cervical intraepithelial neoplasia grade 3

1 reference

12 December 2020

Atypical squamous cells and low-grade squamous intraepithelial lesion in cervical cytology: cytohistological correlation and implication for management in a low-resource setting

1 reference

12 December 2020

Evaluation of the HPV L1 capsid protein in prognosis of mild and moderate dysplasia of the cervix uteri.

1 reference

12 December 2020

Assessment of fluorescence in situ hybridization and hybrid capture 2 analyses of cervical cytology specimens diagnosed as low grade squamous intraepithelial lesion for the detection of high grade cervical intraepithelial neoplasia

1 reference

12 December 2020

Human papillomavirus messenger RNA assay for cervical cancer screening: the Shenzhen Cervical Cancer Screening Trial I

1 reference

12 December 2020

Cervical cancer screening

1 reference

12 December 2020

The value of p16 in ASCUS cases: A retrospective study using frozen cytologic material

1 reference

12 December 2020

Human papillomavirus genotyping as a predictor of high‐grade cervical dysplasia in women with mildly cytologic abnormalities: A two‐year follow‐up report

1 reference

12 December 2020

Worldwide burden of cervical cancer in 2008.

1 reference

12 December 2020

A population-based clinical trial comparing endocervical high-risk HPV testing using hybrid capture 2 and Cervista from the SHENCCAST II Study

1 reference

12 December 2020

The role of p16(INK4a) immunostaining in the risk assessment of women with LSIL cytology: a prospective pragmatic study

1 reference

12 December 2020

Genotyping of human papillomavirus in triaging of low-grade cervical cytology

1 reference

12 December 2020

Use of high‐risk human papillomavirus testing in patients with low‐grade squamous intraepithelial lesions

1 reference

12 December 2020

Comparison of different commercial methods for HPV detection in follow-up cytology after ASCUS/LSIL, prediction of CIN2-3 in follow up biopsies and spontaneous regression of CIN2-3

1 reference

12 December 2020

Value of P16 expression in the triage of liquid-based cervical cytology with atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions

1 reference

12 December 2020

Prediction of cervical intraepithelial neoplasia grade 2 (CIN2 ) using HPV DNA testing after a diagnosis of atypical squamous cell of undetermined significance (ASC-US) in Catalonia, Spain

1 reference

12 December 2020

Performance of high-risk human papillomavirus testing in the triage of abnormal cervical cytology among Chinese younger women in Shanghai, China

1 reference

12 December 2020

[Immunocytochemistry of p16(INK4a) and Ki-67 as adjunctive method for routine gynecological cytology of mild and moderate dysplasia].

1 reference

12 December 2020

Human papillomavirus testing for triage of women with low-grade squamous intraepithelial lesions

1 reference

12 December 2020

Atypical squamous cells of undetermined significance in patients with HPV positive DNA testing and correlation with disease progression by age group: an institutional experience.

1 reference

12 December 2020

Colposcopy referral rate can be reduced by high-risk human papillomavirus triage in the management of recurrent atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion cytology in Finland

1 reference

12 December 2020

The Triage of Women with ASCUS Cytology Using Human Papillomavirus DNA Testing

1 reference

12 December 2020

High-risk human papillomavirus testing of women with cytological low-grade squamous intraepithelial lesions.

1 reference

12 December 2020

The 1988 Bethesda System for reporting cervical/vaginal cytological diagnoses. National Cancer Institute Workshop

1 reference

12 December 2020

Causes and management of cervical intraepithelial neoplasia

1 reference

12 December 2020

Atypia in cervical cytology as a risk factor for intraepithelial neoplasia

1 reference

12 December 2020

Cervical intraepithelial neoplasia

1 reference

12 December 2020

Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance

1 reference

12 December 2020

Should all women with cervical atypia be referred for colposcopy: a HARNET study. Harrisburgh Area Research Network

1 reference

12 December 2020

Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types

1 reference

12 December 2020

European Guidelines for Quality Assurance in Cervical Cancer Screening. Europe against cancer programme

1 reference

12 December 2020

Controversies in the management of low-grade cervical intraepithelial neoplasia.

1 reference

12 December 2020

Natural history of cervical intraepithelial neoplasia: a critical review.

1 reference

12 December 2020

Achievable standards, benchmarks for reporting, criteria for evaluating cervical cytopathology. Workshop report

1 reference

12 December 2020

Human papillomavirus DNA detection in cervical specimens by hybrid capture: correlation with cytologic and histologic diagnoses of squamous intraepithelial lesions of the cervix

1 reference

12 December 2020

Diagnostic performance of Hybrid Capture human papillomavirus deoxyribonucleic acid assay combined with liquid-based cytologic study

1 reference

12 December 2020

Human papillomavirus deoxyribonucleic acid detection in mildly or moderately dysplastic smears: A possible method for selecting patients for colposcopy

1 reference

12 December 2020

HPV testing: is it useful in triage of minor Pap abnormalities?

1 reference

12 December 2020

Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy?

1 reference

12 December 2020

Comparison of two tests for detecting carcinogenic HPV in women with Papanicolaou smear reports of ASCUS and LSIL

1 reference

12 December 2020

Risk factors for high-grade cervical intraepithelial neoplasia in patients with mild cytological dyskaryosis: human papillomavirus testing versus multivariate tree analysis of demographic data

1 reference

12 December 2020

Colposcopy for the diagnosis of squamous intraepithelial lesions: A meta-analysis

1 reference

12 December 2020

Reflex human papillomavirus deoxyribonucleic acid testing in women with abnormal Papanicolaou smears

1 reference

12 December 2020

Where's the High-Grade Cervical Neoplasia? The Importance of Minimally Abnormal Papanicolaou Diagnoses

1 reference

12 December 2020

The clinical value of digene hybrid capture HPV DNA testing in a referral-based population with abnormal pap smears

1 reference

12 December 2020

Is human papillomavirus testing an effective triage method for detection of high-grade (grade 2 or 3) cervical intraepithelial neoplasia?

1 reference

12 December 2020

Evaluation of atypical and low-grade cervical cytology in private practice

1 reference

12 December 2020

Natural history of cervical squamous intraepithelial lesions: a meta-analysis

1 reference

12 December 2020

Does typing of human papillomavirus assist in the triage of women with repeated low-grade, cervical cytologic abnormalities?

1 reference

12 December 2020

10.1002/14651858.CD008054.PUB2

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

543741

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457841&resulttype=core&format=json

release_fznp5xm4jnbnhbtdagvke26x6a

13 May 2020

Fatcat ID

0 references

543741

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457841&resulttype=core&format=json

13 May 2020

2 references

Consolidated OpenCitations Corpus – April 2017

543741